Mind Map Valvular Heart disease

Mind Map Valvular Heart disease

Mind Map: Valvular

Primary Diagnosis:  ­­­­­­­­­­Valvular Heart Disease

Describe the pathophysiology of the primary diagnosis. What are the patient’s risk factors for this diagnosis?

Pathophysiology of Primary Diagnosis

Valvular heart disease (VHD) or heart valve disease is a cardiovascular disorder characterized by the impairment and functioning of least one of the heart’s valves. According to Aluru et al. (2022), the heart has four valves; aortic, mitral, pulmonic, and tricuspid. These valves play the role of preventing backward flow of blood among the four chambers of the heart and maintain the pressure gradient essential for the hemodynamic circulation. The insufficiency of or regurgitation form the valves allow backward flow of blood, leading to pressure equalization that can be discordant with cardiovascular function.  on the other hand, the valvular stenosis leads to an increase in pressure behind the blockage and often lead to cardiac remodeling along with inadequate pressures ahead  the of the blockage(Aluru et al., 2022).

Mitral regurgitation, Mitral stenosis, aortic regurgitation and aortic stenosis, are the most common forms of VHD. According to Nishumura et al. (2025), aortic stenosis leads to a rise in afterload to the left ventricle.  To stabilize the rise in valve stress, there is the development of compensatory concentric hypertrophy by the left ventricle with a rise in thickness of the wall and preserved ejection fraction.  Ejection fraction only drops when the capability of the left ventricle to stabilize wall stress is overwhelmed by the afterload. The persistent pressure ultimately cause interstitial fibrosis along with myocyte degeneration, and further lead to myocardial dysfunction (Nishumura et al., 2025).

Aortic regurgitation occurs when the aortic root becomes enlarged or the aortic valve cusps become abnormal, or both. This leads to a rise in preload and afterload on the left ventricle. The maintenance of both systolic function of the left ventricle and wall stress is through chamber dilation along with hypertrophy.  The major pathophysiological abnormality of mitral stenosis is an increase of pressure in the left artery reflected back by pulmonary circulation, which leads to pulmonary hypertension and failure of the left ventricle. The left atrium undergoes dilation and fibrosis, leading to atrial arrthymis. The enduring pressure along with volume overload causes interstitial fibrosis as well as myocyte degeneration, with a reduction in myocardial function, all occurring before commencement of symptoms (Nishimura et al., 2025) Mind Map Valvular Heart disease.

Mitral regurgitation can  be as a result of valve leaflets(primary mitral regurgitation) or left ventricular abnormality, which leads to alteration in  mitral valve apparatus(secondary mitral regurgitation. The pathophysiology of mitral regurgitation involves blood expulsion into the low-impedance left atrium. The low afterload facing the left ventricle during expulsion leads to a rise in ejection fraction and a reduction in end-systolic volume.   Secondary mitral regurgitation occurs due to left ventricular disease.  Ischemic mitral regurgitation is caused by abnormalities in regional wall motion within the inferolateral distribution which have effects on the posterior medial papillary muscles, leading to posterior leaflet retraction. Systolic function of the left ventricle as a result of cardiomyopathies might lead to a central jet of mitral regurgitation due to symmetric retraction of chordae and papillary muscles (Nishimura et al., 2025).

Causes

Risk Factors (genetic/ethnic/physical)

VHD occurs when one of the heart valves either develops a defect or sustains damage. The damage can be acquired congenital. The two major categories of VDH are valvular insufficiency and valvular stenosis. Valvular stenosis occurs when valve leaflets stiffen and become less elastic, which can make the valve to narrow and subsequently reduce the flow of blood. On the other hand, valvular regurgitation occurs when valve leaflets fail to close completely, resulting in the development of leakage or regurgitate flow (Adere et al., 2023).

Age, exposure to radiotherapy, overweight diabetes, and genetics are risk factors of VDH. According to Santangelo et al. (2023), older individuals are at a high risk of developing VHD and the occurrence of aortic stenosis in persons above 75 years is around 40 percent. Hypercholesterolemia and obesity together with inflammation in individuals aged 50 is connected with aortic valve degeneration. Diabetes is a predisposing factor to the development and faster progression of aortic stenosis Mind Map Valvular Heart disease.

Exposure of mediastinum to radiotherapy is connected with substantial abnormalities of valves, particularly mitral and aortic valves, often presenting as progressive thickening and calcification of valves and eventually leading to restriction and dysfunction of a valve, which manifest as regurgitation and/ or stenosis. Diverse genetic syndromes such as Turner’s syndrome and Marfan syndrome are connected with Aortic regurgitation. FBN1 gene mutation in Marfan syndrome results in progressive dilation of aortic r root and the subsequent occurrence of aortic regurgitation (Santangelo et al., 2023).

Hypertension, particularly diastolic hypertension is a risk factor for both aortic valve regurgitation and aortic root dilation. The risk factors for progression of aortic regurgitation include  diagnosis at a younger age, male gender, and the presence of

Bicuspid Aortic Valve. In mitral stenosis, factors like high systolic blood pressure, obesity, dyslipidemia, and smoking predisposes the mitral valve apparatus to calcification and also contributes to the development of calcific aortic valve disease an indication of the regular co-existence of the stenosis the mitral valve and aortic valve (Santangelo et al., 2023).

 

 

What are the patient’s signs and symptoms for this diagnosis? How does the diagnosis impact other body systems and what are the possible complications?

Signs and Symptoms – Common presentation

How does the diagnosis impact each body system?  Complications?

Common symptoms of VHD include chest discomfort or pain, lightheadedness or dizziness, shortness of breath, particularly when lying down or during physical activity, and swelling in the abdomen, feet, or ankles. Additional symptoms include irregular heartbeats and heart palpitations. According to Nishimura et al. (2025), clinical presentation of aortic stenosis include angina, syncope, and dyspnea. Dyspnea and angina have a direct relationship with hypertrophy of the left ventricle, which results in an oxygen demand mismatch and diastolic dysfunction due to the noncompliant, thick ventricle.

In atrial regurgitation, shortness of breath and chest discomfort occur as a result of diastolic pressure elevation and mismatch in myocardial oxygen demand respectively (Nishimura, et al., 2025).

Primary symptoms of mitral stenosis include dyspnea with exertion from elevation in pressure in the left atrium exacerbated by the reduced period in diastolic filling and fatigue as a result of low output. As mitral stenosis progresses, there is paroxysmal nocturnal dyspnea, hemopytis, orthopnea, as well as symptoms left-sided heart failure. Mitral regurgitation symptoms mainly occur due to the reflection of a huge amount of blood into the pulmonary vasculature and left atrium, leading to orthopnea,   paroxysmal nocturnal dyspnea, and dyspnea. Also, there is a reduction in forward flow, leading to symptoms of fatigue (Nishimura et al., 2025).

VHD have significant impacts on the cardiovascular system by affecting the flow of the blood via the four valves of the heart, resulting to possible strain on the heart.  Subsequently, the respiratory system can be affected by causing buildup of fluids in the lungs or pulmonary hypertension. The musculoskeletal system is indirectly affected by VDH due to a reduction in physical capacity along with exercise tolerance, affecting overall functional ability. Frankel and  Nguyen (2021) indicate that if not treated, VHD can lead to life-threatening complications such as irregular heart rhythms, heart failure, and stroke Mind Map Valvular Heart disease.

 

What are other potential diagnosis that present in a similar way to this diagnosis (differentials)?

Pulmonary edema, obstructive sleep apnea and chronic obstructive pulmonary disease can be mistaken for VDH since these conditions have similar symptoms such as fatigue and shortness of breath, and since they can cause pulmonary hypertension, which can worsen or mimic heart valve problems.

 

What diagnostic tests or labs would you order to rule out the differentials for this patient or confirm the primary diagnosis?

A patient presenting with symptoms of VHD should initially be evaluated with transthoracic echocardiography (TTE), chest radiography, and electrocardiography. The aim of the electrocardiogram is to check heart rhythm and presence of hypertrophy or infarction. A chest cardiograph is valuable in showing if pulmonary congestion is present or not. Two-dimensional TTE assesses the morphology and motion of the valves and also the response of cardiac chambers. Transesophageal echocardiography should be performed   is TTE is unable to sufficiently visualize cardiac structures, in particular mitral valve and left atrium which are on the posterior area of the heart(Nishimura et al., 2025).

Doppler echocardiography is used to establish how severe a valve lesion is, offering valve area and valve gradient for stenotic lesions. It can also establish a valve lesion’s physiologic sequence through the examination of pulmonary pressures and diastolic filling.  If TTE fails to offer all the informational needed for making of clinical decisions, computed tomography (CT) scans and Cardiac magnetic resonance imaging (MRI) should be performed to offer high-resolution images of great vessels and myocardium and also myocardium tissue characterization. These imaging approaches are useful in assessing morphology and motion of the valves, and assessing abnormal velocities of flow of blood that occurs as a result of valve lesions might act as another method of establishing severity of valve lesions. (Nishimura et al., 2025).

 

What treatment options would you consider? Include possible referrals and medications.

There is no medication that can cure VHD. Transcatheter aortic valve replacement or surgical aortic valve replacement is the only medical intervention for aortic stenosis.  There does not exist medical therapy to modify aortic regurgitation from progressing, but in bicuspid aortic valve and Marfan syndrome, the utilization of losartan connected with atenolol lessen the rate at which the aortic root dilates. Acute development of mitral regurgitation is treated through surgery, and in instances of the rupture of the papillary muscles, there is the need for valve replacement (Santangelo et al., 2023) Mind Map Valvular Heart disease.

Symptomatic individuals with severe mitral stenosis are eligible for mitral commissurotomy, and when I contraindicated, a mitral valve surgery or replacement. Mitral annulus calcification is the hallmark of mitral stenosis, which is marked by a condensed calcification at the mitral lefalets’ base between the left atrium and left ventricle, is the hallmark of mitral stenosis. Mitral annulus calcification is connected with heighted cardiovascular events and all-cause mortality as well. When mitral annulus calcification occurs, valvular dysfunction is likely to occur, with subsequent implement for the treatment of mitral valve. In fact, patients experiencing mitral annulus calcification are usually older and comorbid, and because of the greatly calcific mitral valve apparatus, they possess intensely challenging anatomies that are unsuitable for repair.  Thus, there is the delay of surgery for mitral vulvar disease associated with mitral annulus calcification until symptoms become immensely limiting (Santangelo et al., 2023).

References

Adere, A., Bedru, M., & Afewok, M.  (2023). Etiologies and Patterns of Valvular Heart Disease Among Cardiac Patients at the Cardiac Center of Ethiopia During February 2000 to April 2022.  
International Journal of General medicine, 16,
2849-2856.
https://doi.org/10.2147/IJGM.S420591

Aluru, J. S., Barsouk, A., Saginala, K., Rawla, P., & Barsouk, A. (2022) Valvular Heart Disease Epidemiology.
Medical Sciences, 10
(2):32. doi:
10.3390/medsci10020032

Frankel, W. C., & Nguyen, T. C. (2021). Artificial Heart Valves.
JAMA Network, 25
(24), 2512-2513. doi:10.1001/jama.2020.19936

Nishimura, R. A., Ommen, S. R., Dearani, J. A.,  & Schaff, H. V. (2025). Valvular Heart Disease—A New Evolving Paradigm.
Mayo Clinic Proceedings, 100
(2), 358-379. https://doi.org/10.1016/j.mayocp.2024.11.001

Santangelo, G., Bursi, F., Faggiano, A., Moscardelli, S., Simeoli, P. S., Guazzi, M., Lorusso, R., Carugo, S., & Faggiano, P. (2023). The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management.
Journal of Clinical Medicine, 12
(6), 2178. doi:
10.3390/jcm12062178
  Mind Map Valvular Heart disease

Mind Map Valvular heart disease

example: https://www.canva.com/design/DAGSVYSqELE/-B0IoK4WLywd5DShmsuCWQ/edit?utm_content=DAGSVYSqELE&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton

Select one of the possible topics provided and complete the MindMap.

Describe the Pathophysiology and Etiology of the primary diagnosis. List risk factors related to the primary diagnosis.

Mind Map Valvular Heart disease